drugset / Trial / NCT00865631
A Limited Food Effect Study of Gabapentin 800 mg Tablets
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to compare the relative bioavailability of 800 mg Gabapentin Tablets by Purepac Pharmaceutical Co. with that of 400 mg (2 x 400 mg) NEURONTIN® by Parke-Davis following a single oral dose (1 x 800 mg tablet) or (2 x 400 mg capsules) in healthy adult male volunteers under non-fasting conditions, and will compare the differences in plasma levels after dosing the test formulation with and without food.
Timeline
- Start
- 1999-06
- Primary completion
- 1999-06
- Completion
- 1999-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 800 mg | Oral |
Indications
No indication recorded.